Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90

Stefan Karrasch (Neuherberg, Germany), Stefan Karrasch, Irene Brüske, Maia Smith, Joachim Heinrich, Rolf Holle, Karl-Heinz Ladwig, Annette Peters, Holger Schulz

Source: International Congress 2015 – Epidemiology of respiratory disease
Session: Epidemiology of respiratory disease
Session type: Poster Discussion
Number: 5068
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Stefan Karrasch (Neuherberg, Germany), Stefan Karrasch, Irene Brüske, Maia Smith, Joachim Heinrich, Rolf Holle, Karl-Heinz Ladwig, Annette Peters, Holger Schulz. Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90. Eur Respir J 2015; 46: Suppl. 59, 5068

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early detection of undiagnosed COPD in general practice; the yield of population-based screening according to socioeconomic status
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016



Case-finding for COPD: Developing strategies to identify patients at risk populations
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

Burden of comorbidities and NT-proBNP concentrations in stable COPD patients
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013


Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Impact of the nutritional status on pulmonary function in COPD patients
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Tackling under-diagnosis of COPD using spirometry and questionnaire: A targeted, case-finding study
Source: International Congress 2015 – Epidemiology, public health and economics of tobacco
Year: 2015


COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Addressing current gaps in the clinical utility of lung clearance index (LCI) in school aged children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015


Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015



Population based study on the prevalence of COPD by spirometric criteria
Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD
Year: 2010


Impact of frailty on interpretability of spirometry: The Rotterdam study
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Use of clinical characteristics to predict spirometric classification of obstructive lung disease
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Validation of a Japanese version of the COPD diagnostic questionnaire in the general Asian population: The Hisayama study
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

COPD symptoms/diagnoses and work exposure: A 20 years population-based survey
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

The characteristics of ACOS in a population based asthma cohort
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016